NEW SUBSTANCE FOR EYE OINTMENTSCREATION
DOI:
https://doi.org/10.14739/2409-2932.2014.2.25993Keywords:
substance, flurenizyd, eye ointmentsAbstract
Purpose.To describe the use of substances for the manufacture of eyeointments in Ukraine and the relevance of new soft medicinal forms using flurenizyd for ophthalmology.
Materials and methods. We have performed information search in the sources of specialized scientific literature, regulations of the Ministry of Health of Ukraine, directories of domestic pharmaceutical manufacturers.
Results and discussion.According to scientific literature review, the content of the state register of medicines in Ukraine, assortment of soft drugs, approved for medicinal use in Ukraine in 2013, constitutes approximately 556 items, 340 of which are of foreign production (61%) and 216 (39 %) domestic ones. The range of soft ointment medicines constitutes 255 (46%) items and only 9 (3,5%) items of eye soft drugs of exclusively foreign production.From the literature review it has been shown that the immediate task is the development, standardization and application of high-efficacy technology of soft medicinal forms in ophthalmology. It is also important to find effective active ingredients of antibacterial and antiviral action. Complex scientific investigation of new soft dosage forms, based on flurenizyd, has been conducted at various departments of DanyloHalytskyLvivnational medical university.
Flurenizyd attracted the attention of researchers for its wide spectrum of antimicrobial action. Flurenizyd is effective in the treatment of many infectious diseases, including especially dangerous ones – chlamydia and tuberculosis.The first experimental, preclinical and clinical studies of flurenizyd as ophthalmological ointment have been conducted at the Department of ophthalmology DanyloHalytskyLviv national medical university. The ointment proved effective in the treatment of eyeburns and bacterial keratitis (experimental clinical research).The concentration of flurenizyd ointment is optimal for clinical use. Three different concentrations (0.25%, 0.5% and 1%) of ointment have been investigated. The best clinical effect in ophthalmology is provided with 1% ointment.
Thoroughly studied pharmacological properties of 1% flurenizyd ointment proved its wide range of antimicrobial and antiviral activities in the perspective of ophthalmological practice.
Conclusions
1.The modern marketof softdrugs in ophthalmology has beenrepresented byforeign production.
2. It is important to findeffectiveactivesubstances of antibacterialandantiviral activityof domestic productionand their developmentonthe basis ofeyeointments.
3.Completed experimentaland clinical studiesof antibacterial1%flurenizyd ointmentis also effectivein the caseof experimentalcorneoscleraleyes.
4.1%ophthalmologicalointmentflurenizydis perspective forimplementation intodomestic production.
References
(2001). Derzhavna Farmakopeia Ukrainy. [State Pharmacopoeia of Ukraine]. Kharkiv: RIREG [in Ukrainian].
(2012). Derzhavnyi formuliar likarskykh zasobiv [State Form medicines]. Kyiv. [in Ukrainian].
Zavalko, I. V. (2013). Analiz asortymentu oftalmologichnykh likarskykh zasobiv na rynku Ukrainy [Analysis of the range of ophthalmic medicines in Ukraine]. Farmatsevtychnyi zhurnal, 1, 21–26 [in Ukrainian].
Nakaz Ministerstva okhorony zdorovia Ukrainy Instryktsiia do medychnoho zastosunannia preparatu Flurenizyd [Instructions for medical use of the drug Flurenizyd (Flurenizidum)]. 16 zhovtnia 2001 roku № 408 Retrieved from http://www.mozdocs.kiev.ua/likiview.php?id=20066 [in Ukrainian].
Kovalenko, V. N. & Viktorov, A. P. (Eds.) (2012). Kompendium. Liekarstvennyie preparaty [Compendium. Pharmaceuticals preparations]. Kyiv: MORION [in Ukrainian].
Kukuruza, L. V. & Yurevych, V. R. (2013). Pro aktualnist zastosuvannia 1% flurenizydovoi mazi pry infektsiinykh urazhenniakh ochei [The relevance of the application of 1% ophtalmological ointment flurenizyd in infectious eye disease]. Suchasni problemy epidemiologii, mikrobiologii, higiieny ta tuberkulozu Proceedings of the 10-q Scientific and Practical Conference, (Vols 10). (pp. 70-73). Lviv [in Ukrainian].
Mykhalyk, O. I., Petrukh, L. V. & Yurevych, V. R. (2007). Nova ochna flurenizydova maz [New ophtalmological ointment flurenizyd]. Naukovo-tekhnichnyi progres i optymizatsiia tekhnologichnykh protsesiv stvorennia likarskykh zasobiv. Abstracts of Papers. (pp. 46–47). Ternopil [in Ukrainian].
Mykhalyk, O. I., Shelepeten, L. S., Yurevych, V. R. & Petrukh, L. V. (2013). Aktualnist zactocyvannia 1% flurenizydovoi mazi v oftalmologii [The relevance of the use of 1% ointment flurenizyd in ophthalmology]. Tezy XII zizdu VULT (Vseukrainskoho likarskoho tovarystva). Abstracts of Papers. (pp. 195). Kyiv [in Ukrainian].
Nakaz Ministerstva okhorony zdorovia Ukrainy Klasyfikator likarskykh form vid 26 chervnia 2002 roku, № 235. Retrieved from http://www.apteka.ua/article/33289 [in Ukrainian].
Nastanova ST-H MOZU 42-3.0:2011 (n.d.). Likarski zasoby. Farmatsevtychna rozrobka (ICHQ8) vid 2011 roku. Retrieved from http://www.morion.ua/books/66/ [in Ukrainian].
Nastanova z yakosti. Likarski zasoby. Farmatsevtychna rozrobka vid 2004 roku. Retrieved from http://www.morion.ua/books/66/ [in Ukrainian].
Petrukh, L. I. (patentee) Pat. 20624 A, MKV A61F 9/00. Ochna maz dlia likuvannia opikiv i bakteriinykh zapalen rohivky [Eye ointment to treatment burns and bacterial inflammation of the cornea]. № 97031046; zaiavl. 11.03.97; opubl. 27.02.98. Biul., 1 [in Ukrainian].
Petrukh, L. I. (patentee) Pat. 81084, МPK (2006) А61К 31/12, А61К 31/465, А61Р 31/14 (2006.01), А61Р 31/16 (2006.01). Zastosuvannia N-(9-fluoreniliden)-N’-izonikotynohidrazydu (flurenizydu) yak antyvirusnoho zasobu shchodo RNK-genomnykh virusiv [The use of N-(9-fluoreniliden)-N'-izonikotynohidrazyd (flurenizyd) as antiviral agents on RNA virus genome]. № а 2006 10006; zaiavl. 18.09.06; opubl. 26.11.07. Biul, 19 [in Ukrainian].
Petrukh, L. I. (2008). Fluoreny yak tuberkulostatyky. Flurenizyd: mikrobiolohichni, farmakolohichni ta klinichni aspekty [Fluorene as tuberkulostatyks. Flurenizyd: microbiological, pharmacological and clinical aspects]. Lviv [in Ukrainian].
Petrukh, L. I., Mykhalyk O. I., Proniuk, O. V., & Mykhayliuk, N. I. (2002). Biolohichna dostupnist flurenizydu [Bioavailability of flurenizyd]. Tezy dop. IX Kongres SFULT . Abstracts of Papers IX Congress WFUMA. (p. 467–468). Luhansk.
Petrukh, L. I., Nizeskyi, Yu. M., Mykhalyk, O. I., & Pronyuk, O. V. (2002). O svoistvakh novoho protivomikrobnoho perparata flurenizida [The properties of a new antimicrobial flurenizid]. Chelovek i lekarstvo. Abstracts of Papers. (p. 677). Moscow [in Russian].
Pertsev, I. M. (Ed.). (2007). Farmatsevtychni ta medyko-biolohichni aspekty likiv [Pharmaceutical and biomedical aspects of medicine]. Vinnytsia: Nova knyha [in Ukrainian].
Petrukh, L. I. & Pavlenko, O. V. (2012). Flurenizyd vid syntezu do likarskoho preparatu v standartakh likuvannia tuberkulozu i khlamidiozu [Flurenizyd of synthesis to the drug in the standard treatment of tuberculosis and chlamydiosis]. Lviv: Naukove tovarystvo imeni Shevchenka [in Ukrainian].
Yurevych, V. R. (2000). Doklinichni doslidzhennia ranozahoiuvalnoi ta alerhennoi dii 1% flurenizydovoi mazi, pryznachenoi dlia likyvannia khimichnykh opikiv ochei ta bakteriinych zapalen rohivky [Preclinical study of wound healing and allergenic action flurenizyd 1% ointment for the treatment of chemical burns of the eyes and bacterial inflammation of the cornea]. Arkhiv klinicheskoj i eksperimentalnoj mediciny, 9(2), (pp. 251–253). [in Ukrainian].
Yurevych, V. R. (2003). Efektyvnist flurenizydovoi mazi u likuvanni opikiv ochei ta bakteriinykh keratytiv (eksperymentalno-klinichne doslidzhennia) (Avtoref. dis…kand. med. nauk). [Efficiency flurenizyd ointment in the treatment of burns of eyes and bacterial keratitis (experimental clinical research)]. (Extended abstract of candidate’s thesis). Odessa [in Ukrainian].
Yurevych, V. R. & Kukuruza, L. V. (2011). Zastosuvannia flurenizydu v oftalmolohii [Application flurenizyd in ophthalmology]. Tezy dop. Natsionalnoho zizdu Farmakolohiv Ukrainy. Abstracts of Papers, (pp. 368–369). Kyiv [in Ukrainian].
Swarbick, J. (Ed). (2007) Encyclopedia of pharmaceutical technology. Third Edition. New York. London: Informa healthcare.
Yurevych, V. R., & Tunytsya, O. Y. (2001) Preclinical investigations of 1% flurenizid ointment intended for treatment of chemical eye burns. XIII Congress of the European Society of Ophthalmology. Istanbul.
Yurevych, V. R. (2003) Clinical investigations of 1% flurenizid ointment intended for treatment of hemical eye burns. XIV Congress of the European Society Ophthalmology. (p. 158). Madrid.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
